{"id":8053,"date":"2025-02-19T10:10:55","date_gmt":"2025-02-19T10:10:55","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=8053"},"modified":"2025-02-20T15:28:19","modified_gmt":"2025-02-20T15:28:19","slug":"sammed-abre-envio-do-relatorio-de-comercializacao","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/","title":{"rendered":"Sammed Dispon\u00edvel para Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o"},"content":{"rendered":"<div data-olk-copy-source=\"MessageBody\">\n<div data-olk-copy-source=\"MessageBody\">\n<p data-pm-slice=\"1 1 []\">A <strong>Secretaria-Executiva da C\u00e2mara de Regula\u00e7\u00e3o do Mercado de Medicamentos (SCMED)<\/strong> informou que o <strong>Sistema de Acompanhamento do Mercado de Medicamentos (Sammed)<\/strong> est\u00e1 dispon\u00edvel para o envio do relat\u00f3rio de comercializa\u00e7\u00e3o referente ao <strong>segundo semestre de 2024<\/strong>.<\/p>\n<h3><strong>Prazo para Envio<\/strong><\/h3>\n<p>O prazo para o envio do relat\u00f3rio ser\u00e1 at\u00e9 as <strong>23h59min do dia 14 de mar\u00e7o de 2025<\/strong>.<\/p>\n<p>\u00c9 importante destacar que <strong>relat\u00f3rios enviados fora deste prazo n\u00e3o ser\u00e3o aceites.\u00a0<\/strong><\/p>\n<h3><strong>Import\u00e2ncia do Envio no Prazo<\/strong><\/h3>\n<p>Somente as empresas que enviarem o relat\u00f3rio dentro do prazo ter\u00e3o direito ao <strong>ajuste m\u00e1ximo de pre\u00e7os de medicamentos em 2025<\/strong>, conforme o <strong>Comunicado n\u00ba 11 da CMED, de 12 de agosto de 2015<\/strong>.<\/p>\n<h3><strong>Como Fazer o Envio<\/strong><\/h3>\n<p>O envio deve ser realizado exclusivamente por meio do <strong>Sammed<\/strong>.<\/p>\n<p>Para garantir que o processo seja feito corretamente, consulte o<a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/medicamentos\/cmed\/informes\/sammed-manual-do-usuario-relatorios-de-comercializacao-2025r2s2024.pdf\/view\"><strong> Manual do Relat\u00f3rio de Comercializa\u00e7\u00e3o<\/strong><\/a>, que cont\u00e9m todas as orienta\u00e7\u00f5es sobre preenchimento e envio.<\/p>\n<\/div>\n<h3><strong>D\u00favidas?\u00a0<\/strong><\/h3>\n<div data-olk-copy-source=\"MessageBody\">\n<p>Entre em contato com a <strong>Anvisa<\/strong> pelo e-mail <strong><a class=\"ProsemirrorEditor-link\" href=\"mailto:sammed@anvisa.gov.br\">sammed@anvisa.gov.br<\/a><\/strong>. Para agilizar o atendimento, n\u00e3o se esque\u00e7a de incluir no t\u00edtulo da mensagem: <strong>[SCMEDCOMERCIALIZA\u00c7\u00c3O-2025-2s2024-D\u00daVIDA]<\/strong>.<\/p>\n<p>Al\u00e9m disso, os outros canais de atendimento da Anvisa tamb\u00e9m est\u00e3o dispon\u00edveis para esclarecer d\u00favidas adicionais. Garanta que sua empresa esteja em conformidade para o ajuste de pre\u00e7os em 2025!<\/p>\n<\/div>\n<p data-start=\"0\" data-end=\"67\">Se tiver d\u00favidas sobre <em>compliance<\/em>, a<a href=\"https:\/\/els-solutions.com\/servicos\/\"> <strong data-start=\"39\" data-end=\"52\">ELS Group<\/strong> pode ajudar!<\/a><\/p>\n<p data-start=\"69\" data-end=\"172\" data-is-last-node=\"\">Entre em contato com o seu consultor local da <a href=\"https:\/\/els-solutions.com\/onde-estamos\/\"><strong data-start=\"115\" data-end=\"122\">ELS<\/strong> <\/a>ou envie um e-mail para <strong data-start=\"147\" data-end=\"171\"><a rel=\"noopener\" data-start=\"149\" data-end=\"169\">info@elssolutions.pt<\/a><\/strong>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>O Sammed estar\u00e1 dispon\u00edvel para o envio do relat\u00f3rio de comercializa\u00e7\u00e3o do segundo semestre de 2024. Enviar no prazo garante o ajuste m\u00e1ximo de pre\u00e7os de medicamentos em 2025.<\/p>\n","protected":false},"author":9,"featured_media":8055,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,67,68,53,60,69],"tags":[],"class_list":["post-8053","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-anvisa","category-els","category-els-group","category-geral","category-noticias","category-questoes-regulatorias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sammed Abre Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o<\/title>\n<meta name=\"description\" content=\"A SCMED informa que o Sammed estar\u00e1 dispon\u00edvel para o envio do relat\u00f3rio de comercializa\u00e7\u00e3o at\u00e9 dia 14 de mar\u00e7o de 2025.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa\" \/>\n<meta property=\"og:description\" content=\"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa para garantir o abastecimento de produtos cr\u00edticos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T10:10:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-20T15:28:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Sammed Dispon\u00edvel para Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o\",\"datePublished\":\"2025-02-19T10:10:55+00:00\",\"dateModified\":\"2025-02-20T15:28:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/\"},\"wordCount\":270,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png\",\"articleSection\":[\"ANVISA`\",\"ELS\",\"ELS Group\",\"Geral\",\"Not\u00edcias\",\"Quest\u00f5es regulat\u00f3rias\"],\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/\",\"name\":\"Sammed Abre Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png\",\"datePublished\":\"2025-02-19T10:10:55+00:00\",\"dateModified\":\"2025-02-20T15:28:19+00:00\",\"description\":\"A SCMED informa que o Sammed estar\u00e1 dispon\u00edvel para o envio do relat\u00f3rio de comercializa\u00e7\u00e3o at\u00e9 dia 14 de mar\u00e7o de 2025.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sammed Dispon\u00edvel para Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#website\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/pt-pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sammed Abre Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o","description":"A SCMED informa que o Sammed estar\u00e1 dispon\u00edvel para o envio do relat\u00f3rio de comercializa\u00e7\u00e3o at\u00e9 dia 14 de mar\u00e7o de 2025.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"pt_PT","og_type":"article","og_title":"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa","og_description":"Atualizam a lista de medicamentos com exporta\u00e7\u00e3o suspensa para garantir o abastecimento de produtos cr\u00edticos.","og_url":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2025-02-19T10:10:55+00:00","article_modified_time":"2025-02-20T15:28:19+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Marketing ELS","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Sammed Dispon\u00edvel para Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o","datePublished":"2025-02-19T10:10:55+00:00","dateModified":"2025-02-20T15:28:19+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/"},"wordCount":270,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png","articleSection":["ANVISA`","ELS","ELS Group","Geral","Not\u00edcias","Quest\u00f5es regulat\u00f3rias"],"inLanguage":"pt-PT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/","url":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/","name":"Sammed Abre Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o","isPartOf":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png","datePublished":"2025-02-19T10:10:55+00:00","dateModified":"2025-02-20T15:28:19+00:00","description":"A SCMED informa que o Sammed estar\u00e1 dispon\u00edvel para o envio do relat\u00f3rio de comercializa\u00e7\u00e3o at\u00e9 dia 14 de mar\u00e7o de 2025.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2025\/02\/Medicines-Marketing-Report.png","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/pt-pt\/sammed-abre-envio-do-relatorio-de-comercializacao\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"Sammed Dispon\u00edvel para Envio do Relat\u00f3rio de Comercializa\u00e7\u00e3o"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/pt-pt\/#website","url":"https:\/\/els-solutions.com\/pt-pt\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/pt-pt\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/els-solutions.com\/pt-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/8053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=8053"}],"version-history":[{"count":4,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/8053\/revisions"}],"predecessor-version":[{"id":8095,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/posts\/8053\/revisions\/8095"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media\/8055"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=8053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/categories?post=8053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=8053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}